Works matching IS 2160763X AND DT 2020 AND VI 9 AND IP 8

Results: 14

A Review on Drug‐Induced Nephrotoxicity: Pathophysiological Mechanisms, Drug Classes, Clinical Management, and Recent Advances in Mathematical Modeling and Simulation Approaches.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 896, doi. 10.1002/cpdd.879

By:

Mody, Hardik;
Ramakrishnan, Vidya;
Chaar, Maher;
Lezeau, Jovin;
Rump, Adrian;
Taha, Kareem;
Lesko, Lawrence;
Ait‐Oudhia, Sihem

Publication type:

Article

Pharmacokinetics, Safety, and Tolerability of Single‐ and Multiple‐Dose Once‐Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo‐Controlled Study.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 952, doi. 10.1002/cpdd.868

By:

Zhao, Xia;
Sheng, Xiao Yan;
Payne, Christopher D.;
Zhang, Xin;
Wang, Feng;
Cui, Yi Min

Publication type:

Article

Bioequivalence and Pharmacokinetic Evaluation of Two Metformin Hydrochloride Tablets Under Fasting and Fed Conditions in Healthy Chinese Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 910, doi. 10.1002/cpdd.849

By:

Huang, Xiao‐mei;
Wang, Gong‐zhu;
He, Bin‐bin;
Gao, Ting;
Long, Ping;
Zhang, Bi‐kui

Publication type:

Article

A Randomized, Double‐Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid Arthritis.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 1003, doi. 10.1002/cpdd.845

By:

Burmester, Gerd;
Chien, David;
Chow, Vincent;
Gessner, Melissa;
Pan, Jean;
Cohen, Stanley

Publication type:

Article

Effect of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intravenous Rivipansel.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 918, doi. 10.1002/cpdd.842

By:

Tammara, Brinda K.;
Ryan, Kelly;
Plotka, Anna;
Shafer, Frank E.;
Wei, Hua;
Readett, David;
Fang, Annie;
Korth‐Bradley, Joan M.

Publication type:

Article

A Phase 1 Study to Assess the Relative Bioavailability, Food Effect, and Safety of a Tablet Formulation of GSK2838232, a Novel HIV Maturation Inhibitor in Healthy Participants After Single and Repeated Doses.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 972, doi. 10.1002/cpdd.820

By:

Johnson, Mark;
Jewell, Roxanne C.;
Gan, Jianjun;
Dumont, Etienne;
Burns, Olivia;
Johns, Brian A.

Publication type:

Article

Effects of Multiple‐Dose Administration of Aprocitentan on the Pharmacokinetics of Rosuvastatin.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 995, doi. 10.1002/cpdd.815

By:

Sidharta, Patricia N.;
Dingemanse, Jasper

Publication type:

Article

Safety and Pharmacokinetics of High‐Dose TAS‐303 in Healthy Japanese Volunteers: A Single‐Center, Single‐Blind, Randomized, Placebo‐Controlled, Parallel‐Group, Multiple‐Ascending‐Dose Study.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 961, doi. 10.1002/cpdd.801

By:

Hanada, Ryuzo

Publication type:

Article

Pharmacokinetics of Single and Multiple Doses of Omega‐3 Carboxylic Acids in Healthy Chinese Subjects: A Phase I, Open‐Label Study.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 985, doi. 10.1002/cpdd.800

By:

Jing, Shan;
Zhang, Zhenxian;
Chen, Xiaowen;
Miao, Rui;
Nilsson, Catarina;
Lin, Yang

Publication type:

Article

A Single‐Dose, Open‐Label, Randomized, Two‐Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of Daprodustat.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 978, doi. 10.1002/cpdd.793

By:

Yamada, Masanori;
Osamura, Minori;
Ogura, Hirofumi;
Onoue, Tomohiro;
Wakamatsu, Akira;
Numachi, Yotaro;
Caltabiano, Stephen;
Mahar, Kelly M.

Publication type:

Article

The Effect of CYP3A Induction and Inhibition on the Pharmacokinetics of Laquinimod, a Novel Neuroimmunomodulator.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 1015, doi. 10.1002/cpdd.785

By:

Elgart, Anna;
Greenblatt, David J.;
Loupe, Pippa S.;
Zur, Arik A.;
Weiss, Sivan;
Mimrod, Dorit;
Spiegelstein, Ofer

Publication type:

Article

Thorough QT/QTc Study Shows That a Novel 5‐HT<sub>4</sub> Receptor Partial Agonist Minesapride Has No Effect on QT Prolongation.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 938, doi. 10.1002/cpdd.778

By:

Hamatani, Tatsuto;
Noda, Naoto;
Takagaki, Takeshi;
Yodo, Yasuhide;
Kawai, Hirotaka;
Kakuyama, Hiroyoshi;
Kaji, Yoshikazu;
Fujio, Yasushi

Publication type:

Article

Pilot Study to Predict Pharmacokinetics of a Therapeutic Gemcitabine Dose From a Microdose.

Published in:

Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 929, doi. 10.1002/cpdd.774

By:

Van Nuland, M.;
Rosing, H.;
Thijssen, B.;
Burgers, J.A.;
Huitema, A.D.R.;
Marchetti, S.;
Schellens, J.H.M.;
Beijnen, J.H.

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2020, v. 9, n. 8, p. 891, doi. 10.1002/cpdd.682
Publication type:: Article